NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Mukesh Ambani
    WhatsApp
    Reliance Jio
    OPPO
    Vivo
    Sensex
    Bitcoin
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / Business News / AstraZeneca has sold its stake in Moderna for $1 billion
    Business

    AstraZeneca has sold its stake in Moderna for $1 billion

    AstraZeneca has sold its stake in Moderna for $1 billion
    Written by Sagar
    Mar 01, 2021, 11:29 am 2 min read
    AstraZeneca has sold its stake in Moderna for $1 billion

    British pharmaceutical company AstraZeneca Plc has sold its 7.7 percent stake in Moderna Inc., the American pharmaceutical giant, for more than $1 billion, according to a report in The Times. The development comes after the US-based company's share prices soared owing to its coronavirus vaccine breakthrough, the report says. Here are more details on this.

    AstraZeneca could sell COVID-19 vaccine on commercial basis in future

    However, it was not immediately clear over what period AstraZeneca sold its holding in Moderna, the report adds. Separately, AstraZeneca is retaining its partnership with Moderna on other disease treatments and may sell its AstraZeneca/Oxford University COVID-19 vaccine on a commercial basis in the future if and when the virus becomes endemic, said the report.

    Moderna expecting sales of $18.4 billion from vaccine this year

    Meanwhile, Moderna had said last week that it was expecting sales up to $18.4 billion from its coronavirus vaccine this year. Moderna's vaccine had received emergency use authorization in the United States and Canada in December last year, and was cleared for use in the European Union in January 2021. It is said to have an efficacy of more than 90 percent.

    AstraZeneca's vaccine among two being used in India

    AstraZeneca's COVID-19 vaccine, said to be one of the most effective, has been developed in collaboration with the Oxford University. It is also one of two vaccines currently in use in India. The country cleared the vaccine in January, paving the way for a massive inoculation program. It is being manufactured by the Pune-based Serum Institute of India (SII) with the brand name Covishield.

    COVID-19 infected more than 11.46 crore across the globe

    The COVID-19 pandemic, which originated in late 2019 in China, has affected more than 11.46 crore and killed 25.43 lakh around the world. The US remains the worst-affected nation in the outbreak, reporting over 2.92 crore infections and 5.25 lakh deaths. In India, the second worst-hit country, the virus has infected more than 1.11 crore and claimed the lives of over 1.5 lakh.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Coronavirus
    AstraZeneca
    Moderna Inc

    Latest

    BMW i5: Features and specs of the upcoming electric sedan BMW
    Loved 'John Wick: Chapter 4'? Watch these 5 actioners  Hollywood
    5 simple stretches for seniors to kick-start their day Exercise
    Google Bard plagiarism scandal: What you need to know Google Bard

    Coronavirus

    UP: CM holds meeting with Team 9 amid COVID-19 resurgence COVID-19
    India records nearly 1,600 daily COVID-19 cases—highest in 5 months COVID-19
    PM Modi to hold high-level meeting amid rising COVID-19 cases Narendra Modi
    India reports highest daily COVID-19 cases in 2023: Check tally COVID-19 India

    AstraZeneca

    AstraZeneca's antibody cocktail Evusheld effective against Omicron, finds study United States of America
    COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Pfizer
    Kim orders tougher virus steps after North Korea shuns vaccines North Korea
    COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll Oxford University

    Moderna Inc

    Moderna COVID-19 vaccine produces lasting immune response: Study Research
    Japan suspends 1.63mn Moderna vaccine doses after contamination found Japan
    No sign of Pfizer, Moderna vaccines in breast milk: Study Pfizer
    India offered 7.5mn doses of Moderna vaccine under COVAX program Drugs Controller General of India

    Love Business News?

    Subscribe to stay updated.

    Business Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023